Gigabecquerel to Microcurie

The patient swallows a capsule containing 1–7 GBq of I-131. The thyroid gland concentrates iodine from the bloodstream — it cannot tell radioactive iodine from stable iodine — so the isotope accumulates right where you want it. I-131 emits beta particles with a range of about 2 mm in tissue, which destroy thyroid cells from the inside while sparing nearby structures. The gamma rays it also emits are used for imaging to verify uptake. Within weeks the targeted tissue is dead, no scalpel required.

At 3–7 GBq, a freshly treated thyroid cancer patient is a walking radiation source. They emit gamma rays and excrete I-131 in sweat, saliva, and urine for days. Regulations typically require isolation until the retained activity drops below 1.1 GBq or the dose rate at 1 meter falls below 25 µSv/hr. That usually means 2–5 days of sleeping alone, using a dedicated bathroom, and avoiding prolonged close contact — especially with children and pregnant women, who are more radiation-sensitive.

Brachytherapy places a sealed radioactive source directly inside or next to a tumor — "brachy" is Greek for "short distance." High-dose-rate (HDR) sources of iridium-192 at 100–370 GBq deliver an intense, highly localized dose in minutes. The inverse-square law means tissue just centimeters away receives dramatically less radiation. This precision is why brachytherapy can treat cervical, prostate, and breast cancers with fewer side effects than external beam radiation alone.

Industrial radiography sources (1–20 GBq of Ir-192 or Se-75) live inside heavy shielded containers called "cameras" or "projectors" made of depleted uranium or tungsten. The source is only pushed out through a guide tube during an exposure, and the area is roped off with radiation monitors. Strict transport regulations, tamper-proof locks, and regular inventory audits apply. When sources decay below useful activity, they are returned to the manufacturer. The IAEA maintains a database of lost or orphaned sources — the ones that slip through the system occasionally cause severe accidents.

Diagnostic procedures use just enough activity to produce a readable image — typically 50–800 MBq (0.05–0.8 GBq). The goal is information, not tissue destruction. Therapeutic procedures aim to kill cells, so they use 10 to 100 times more: 1–7 GBq for thyroid ablation, 100–370 GBq for HDR brachytherapy sources. The line between them is roughly 1 GBq. Below that, you are taking a picture; above it, you are prescribing a lethal dose to a very specific target.

Because microcuries are the threshold where regulatory accountability begins for most isotopes. A lab ordering 250 µCi of P-32 must log the receipt, track usage, survey for contamination weekly, monitor personnel doses, and account for every fraction disposed of or decayed. Multiply that by dozens of labs across a campus, each using different isotopes with different rules, and you get a full-time radiation safety program. The obsession is not about the hazard of any single vial — it is about preventing the slow accumulation of untracked material that eventually leads to a contamination incident or regulatory violation.

It depends on what the isotope emits. A 100 µCi tritium source needs no shielding at all — the beta particles cannot penetrate a sheet of paper. A 100 µCi phosphorus-32 source (high-energy beta) needs about 1 cm of acrylic to stop the betas, but acrylic is preferred over lead because lead produces bremsstrahlung X-rays from energetic betas. A 100 µCi caesium-137 source (gamma emitter) needs a thin lead container. At microcurie levels the shielding is lightweight and portable — nothing like the heavy lead pigs used for millicurie medical sources.

Most check sources contain 0.1–1 µCi of caesium-137, chosen because Cs-137 has a convenient 662 keV gamma ray and a 30-year half-life — long enough that the source maintains predictable activity for decades without frequent recalibration. The activity is high enough to produce a clear above-background reading (several hundred counts per minute) but low enough to be exempt from most transport regulations. Technicians hold the check source near the detector before each use to verify the instrument is responding. If the reading is off by more than 10–20% from the expected value, the instrument goes back for calibration.

Not from external exposure — the dose rates are far too low. At 1 meter from a 500 µCi unshielded Cs-137 source, the dose rate is about 1.6 µSv/hr, which is only a few times background. The danger from microcurie quantities comes from internal exposure: inhaling or ingesting even micrograms of an alpha emitter like polonium-210 or americium-241 can deliver a concentrated dose to lung or gut tissue. Alexander Litvinenko was killed by roughly 26 µCi of Po-210 dissolved in tea — a quantity invisible to the eye.

Autoradiography uses radioactive decay to make an image — you label DNA or protein with P-32, separate the molecules on a gel, press the gel against X-ray film or a phosphor screen, and the beta particles expose the film wherever your target molecule sits. A typical experiment uses 50–250 µCi, which gives a visible image in hours to overnight. P-32 is favored because its high-energy beta (1.7 MeV) produces sharp, high-contrast bands without the weeks-long exposure times that weaker emitters like S-35 or C-14 require.